Gilead Sciences s.r.o.

Empiria (Regus)
Na Strzi 1702/65
Prague 140 00
Prague 4
Czech Republic

Telephone: +420 222 191 546

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Transparency Reporting
In line with local Transparency Reporting requirements, Gilead is disclosing its interactions with HealthCare Professionals and HealthCare Organisations in Czech Republic in the following report, supported by a Methodological Note. Enquiries about the report should be directed to: http://www.gilead.com/news/media-inquiries.

Gilead Sciences Czech Republic EFPIA Methodological Note 2017 (in Czech)
Gilead Sciences Czech Republic EFPIA Methodological Note 2017 (in English)
Gilead Sciences Czech Republic EFPIA Report 2017
Gilead Sciences Czech Republic EFPIA Methodological Note 2016 (in Czech)
Gilead Sciences Czech Republic EFPIA Methodological Note 2016 (in English)
Gilead Sciences Czech Republic EFPIA Report 2016
Gilead Sciences Czech Republic EFPIA Methodological Note 2015 (in Czech)
Gilead Sciences Czech Republic EFPIA Methodological Note 2015 (in English)
Gilead Sciences Czech Republic EFPIA Report 2015

Relationships with Patient Organizations

Gilead has provided no support to patient organizations in 2017 from the Czech Republic or Slovakia. The information is correct at the time of writing August 2018. The information is subject to change and will be updated accordingly. For a listing of previous years’ support, click here.


This page is intended for visitors outside of the United States.